Skip to Content
COVID-19 Response and Update


We maintain primary operations – including an India corporate office – in Ahmedabad, where five expansive facilities provide wide-ranging oral solid dosage (OSD) and injectables manufacturing, packaging and R&D capabilities. 

In 2022, we expanded our Ahmedabad operations through the acquisition of a 293,000 square foot, world-class injectables manufacturing facility featuring several sterile injectable production lines and advanced capabilities including robotic filling, emulsion, aseptic and lyophilization across large- and small-volume parenterals, vials and bags. 

In Hyderabad, specialized teams deliver oncology products across multiple dosage forms, including liquid vials, lyophilized vials and powder. Amneal also maintains India-based active pharmaceutical ingredient (API) capabilities in Dahej, Rajoda and Vizag. These unique in-house capabilities enable us to develop and supply critical API for several products across our portfolio. 

In addition to these extensive development and production capabilities, Amneal also maintains a commercial sales infrastructure that is supporting our growing India portfolios focused on the hospital, ophthalmic and oncology markets.

Rajoda, Ahmedabad

Solid Oral Dosage

Matoda, Ahmedabad

Solid Oral Dosage, Injectable, Injectable Microsphere

Pipan, Ahmedabad


Palli, Ahmedabad


Raks, Dahej

Active Pharmaceutical Ingredients (API)


Commercial Offices


Oncology Injectables

Raks, Vizag

Active Pharmaceutical Ingredients (API)